FDS
EVH icon

First Dallas Securities’s Evolent Health EVH Stock Holding History

First Dallas Securities’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10,150
Closed -$194K – 124
2024
Q2 		$194K Buy
10,150
+2,350
+30% +$60K 0.09% 116
2024
Q1 		$256K Buy
+7,800
New +$249K 0.12% 112

Other funds holding EVH

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

First Dallas Securities's EVH Position: Q3 2024 in Review

First Dallas Securities sold out of Evolent Health (EVH) in Q3 2024, closing a stake of 10,150 shares — an estimated $194K sold.

First Dallas Securities first reported a position in EVH in Q1 2024 and held it in 2 quarters. The position peaked at $256K in Q1 2024. 262 funds tracked by Wall St. Rank hold EVH as of Q3 2024.

  • First Dallas Securities reported no remaining Evolent Health position as of Q3 2024 after selling out during the quarter.
  • First Dallas Securities sold 10,150 Evolent Health shares in Q3 2024, an estimated $194K.
  • First Dallas Securities first reported a position in Evolent Health in Q1 2024 and held it in 2 quarters.
  • First Dallas Securities's Evolent Health position peaked at $256K in Q1 2024.
  • 262 funds tracked by Wall St. Rank held Evolent Health as of Q3 2024.

Based on First Dallas Securities's 13F filing for Q3 2024, filed 18 Nov 2024.